Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu
    [{"orgOrder":0,"company":"Minakem (formerly Delmar Chemicals)","sponsor":"Adgero Biopharmaceuticals","pharmaFlowCategory":"D","amount":"Undisclosed","upfrontCash":"Undisclosed","newsHeadline":"DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline","therapeuticArea":"Oncology","highestDevelopmentStatus":"Phase II","country":"CANADA","productType":"Small molecule","productStatus":"Approved","date":"June 2020","url1":"","url2":"","graph1":"Oncology","graph2":"Phase II"},{"orgOrder":0,"company":"Minakem (formerly Delmar Chemicals)","sponsor":"Undisclosed","pharmaFlowCategory":"D","amount":"$19.6 million","upfrontCash":"Undisclosed","newsHeadline":"DelMar Announces $19.6 Million Private Placement Priced at-the-Market","therapeuticArea":"Oncology","highestDevelopmentStatus":"Phase III","country":"CANADA","productType":"Small molecule","productStatus":"Approved","date":"August 2020","url1":"","url2":"","graph1":"Oncology","graph2":"Phase III"}]

    Find Clinical Drug Pipeline Developments & Deals by Delmar Chemicals Inc

    Menu

    Delmar Chemicals Inc

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    Loading...

    All Data

    Previous
    Next
    Filters Filter
    ×
    FILTER:
    filter Company
      filter Sponsor
        filter Country
          filter Therapeutic Area
            filter Study Phase

              Active Filter(s):

              refreshFilters
              refreshReset Filter
              refresh Reset Filter
              price-trend All Developments

              Companies By Therapeutic Area

              Development Status

              Minakem (formerly Delmar Chemicals)

              Contact Supplier
              • Deals
              Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids
              Contact Supplier Contact Supplier
              Flag Canada
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              DelMar Announces $19.6 Million Private Placement Priced at-the-Market

              Details:

              Company intends to use the net proceeds from the offering for the previously announced registration study for VAL-083 in newly diagnosed and recurrent glioblastoma multiforme, the 15-patient REM-001 confirmatory lead-in study and for working capital.

              Lead Product(s): Dianhydrogalactitol

              Therapeutic Area: Oncology Product Name: VAL-083

              Highest Development Status: Phase III Product Type: Small molecule

              Partner/Sponsor/Collaborator: Undisclosed

              Deal Size: $19.6 million Upfront Cash: Undisclosed

              Deal Type: Private Placement August 18, 2020

              Minakem Delmar

              CPhI Japan

              Not Confirmed

              envelop Contact Supplier

              Minakem (formerly Delmar Chemicals)

              Contact Supplier
              • Deals
              Virtual BoothMinakem is manufacturing small molecules APIs including corticosteroids
              Contact Supplier Contact Supplier
              Flag Canada
              Virtual Booth Virtual Booth
              Digital Content Digital Content

              DelMar to Acquire Adgero Biopharmaceuticals, Expands Late-Stage Oncology Pipeline

              Details:

              This combination brings together DelMar's first-in-class, DNA-targeting chemotherapeutic with proven anti-cancer activities with Adgero's photodynamic therapy platform.

              Lead Product(s): Dianhydrogalactitol

              Therapeutic Area: Oncology Product Name: Undisclosed

              Highest Development Status: Phase II Product Type: Small molecule

              Recipient: Adgero Biopharmaceuticals

              Deal Size: Undisclosed Upfront Cash: Undisclosed

              Deal Type: Acquisition June 10, 2020

              Minakem Delmar

              CPhI Japan

              Not Confirmed

              envelop Contact Supplier
              Minakem Delmar
              Send me more info on How To Grow My Business Digitally?
              Post Enquiry
              POST ENQUIRY